Proprietary AI analyst is now available

Fragua Valuation Multiples

Discover revenue and EBITDA valuation multiples for Fragua and similar public comparables like DaShenLin Pharmaceutical, Sundrug, COSMOS Pharmaceutical, Ebos Group and more.

Fragua Overview

About Fragua

Corporativo Fragua SAB de CV is engaged in the drug retail sector in Mexico. The company operates a network of pharmacies under the SuperFarmacia brand name, focusing on selling medicines, medical devices, and a variety of other products, including grocery items, exercise machines, perfumes, housewares, electronics, personal care products, toys, and photographic equipment.


Founded

1992

HQ

Mexico

Employees

36.9K

Sectors

Financials (LTM)

Revenue: $8B
EBITDA: $589M

EV

$2B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Fragua Financials

Fragua reported last 12-month revenue of $8B and EBITDA of $589M.

In the same LTM period, Fragua generated $589M in EBITDA and $297M in net income.

Revenue (LTM)


Fragua P&L

In the most recent fiscal year, Fragua reported revenue of $7B and EBITDA of $369M.

Fragua is profitable as of last fiscal year, with gross margin of 23%, EBITDA margin of 5%, and net margin of 4%.

See analyst estimates for Fragua
LTMLast FY202320242025202620272028
Revenue$8B$7B$6B$7B$8B
Gross Profit-$2B$1B$2B-
Gross Margin-23%23%23%-
EBITDA$589M$369M$523M$369M$566M
EBITDA Margin7%5%8%5%7%
EBIT Margin7%4%5%4%7%
Net Profit$297M$283M$260M$283M$282M
Net Margin4%4%4%4%4%

Financial data powered by Morningstar, Inc.

Fragua Stock Performance

Fragua has current market cap of $3B, and enterprise value of $2B.

Market Cap Evolution


Fragua's stock price is $27.36.

Fragua share price decreased by 1.2% in the last 30 days, and by 12.5% in the last year.

Fragua has an EPS (earnings per share) of $2.96.

See more trading valuation data for Fragua
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$2B$3B-0.6%-1.2%-4.5%-12.5%$2.96

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Fragua Valuation Multiples

Fragua trades at 0.3x EV/Revenue multiple, and 4.2x EV/EBITDA.

See NTM and 2027E valuation multiples for Fragua

EV / Revenue (LTM)


Fragua Financial Valuation Multiples

As of June 5, 2026, Fragua has market cap of $3B and EV of $2B.

Fragua has a P/E ratio of 8.8x.

LTMLast FY202320242025202620272028
EV/Revenue0.3x0.4x0.4x0.4x0.3x
EV/EBITDA4.2x6.7x4.7x6.7x4.4x
EV/EBIT4.7x8.8x8.2x8.8x4.8x
EV/Gross Profit-1.5x1.7x1.5x-
P/E8.8x9.3x10.1x9.3x9.3x
EV/FCF12.9xn/m19.0xn/m23.8x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Fragua Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Fragua Margins & Growth Rates

Fragua grew revenue by 10% and EBITDA by 54% in the last fiscal year.

In the most recent fiscal year, Fragua reported gross margin of 23%, EBITDA margin of 5%, and net margin of 4%.

See estimated margins and future growth rates for Fragua

Fragua Margins

Last FY202420252026202720282029
Gross Margin23%23%--
EBITDA Margin5%5%7%8%
EBIT Margin4%4%7%7%
Net Margin4%4%4%4%
FCF Margin0%0%1%4%

Fragua Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth10%10%10%7%
Gross Profit Growth-13%--
EBITDA Growth54%(30%)54%10%
EBIT Growth83%(7%)83%5%
Net Profit Growth(0%)9%(0%)12%
FCF Growth3028%(97%)3028%196%

Data powered by FactSet, Inc. and Morningstar, Inc.

Fragua Operational KPIs

Fragua's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.0M for the same period.

Fragua's Rule of 40 is 15% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Fragua's Rule of X is 25% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Fragua
LTMLast FY20232024202620272028
Rule of 4015%15%--
Bessemer Rule of X26%25%--
Revenue per Employee-$0.2M--
Opex per Employee-$0.0M--
Opex to Revenue-19%18%19%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Fragua Competitors

Fragua competitors include DaShenLin Pharmaceutical, Sundrug, COSMOS Pharmaceutical, Ebos Group, Kusuri No Aoki, Sugi Holdings, Omnicell, Clicks Group, Nahdi Medical and Yifeng Pharmacy.

Most Fragua public comparables operate across Pharmacies.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
DaShenLin Pharmaceutical0.6x0.6x4.7x4.8x
Sundrug0.5x0.5x6.8x6.2x
COSMOS Pharmaceutical0.4x0.4x7.0x7.2x
Ebos Group0.4x0.4x9.0x7.9x
Kusuri No Aoki0.8x0.8x9.9x10.5x
Sugi Holdings0.5x0.5x7.2x7.0x
Omnicell1.6x1.6x13.8x12.9x
Clicks Group1.2x1.2x8.7x8.4x

This data is available for Pro users. Sign up to see all Fragua competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Fragua

When was Fragua founded?Fragua was founded in 1992.
Where is Fragua headquartered?Fragua is headquartered in Mexico.
How many employees does Fragua have?As of today, Fragua has over 36K employees.
Is Fragua publicly listed?Yes, Fragua is a public company listed on Bolsa Mexicana de Valores.
What is the stock symbol of Fragua?Fragua trades under FRAGUAB ticker.
When did Fragua go public?Fragua went public in 1997.
Who are competitors of Fragua?Fragua main competitors include DaShenLin Pharmaceutical, Sundrug, COSMOS Pharmaceutical, Ebos Group, Kusuri No Aoki, Sugi Holdings, Omnicell, Clicks Group, Nahdi Medical, Yifeng Pharmacy.
What is the current market cap of Fragua?Fragua's current market cap is $3B.
What is the current revenue of Fragua?Fragua's last 12 months revenue is $8B.
What is the current revenue growth of Fragua?Fragua revenue growth (NTM/LTM) is 7%.
What is the current EV/Revenue multiple of Fragua?Current revenue multiple of Fragua is 0.3x.
What is the current EBITDA of Fragua?Fragua's last 12 months EBITDA is $589M.
What is Fragua's EBITDA margin?Fragua's last 12 months EBITDA margin is 7%.
What is the current EV/EBITDA multiple of Fragua?Current EBITDA multiple of Fragua is 4.2x.
What is the current FCF of Fragua?Fragua's last 12 months FCF is $191M.
What is Fragua's FCF margin?Fragua's last 12 months FCF margin is 2%.
What is the current EV/FCF multiple of Fragua?Current FCF multiple of Fragua is 12.9x.
How many companies Fragua has acquired to date?Fragua hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Fragua has invested to date?Fragua hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Fragua

Lists including Fragua

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial